The role of transduction signaling protein EP300 mutated in cancer has been evidenced that it activated miRNA MIR17 to negatively regulate target genes BECN1 and CD28 to promote cell proliferation and escape the immune checkpoint [41,42,43]. The gene discussed is BECN1; the disease is cancer.